It starts with a loss of muscle function that worsens over time and eventually leads to problems with the heart and lungs. Approximately 1 in every 3,500 males are born with it. Three companies — San Rafael's BioMarin Pharmaceuticals, PTC Therapeutics ...
By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.
By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.